Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Computer Programs and Systems

Omnicell

Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.

3 MedTech Sectors Benefiting Despite COVID-19 Resurgence

BANNOCKBURN, Ill., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 9,200,000 shares of the Company's common stock at a price to the public of $26.90 per share in an underwritten public offering. The offering is expected to close on September 9, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Pricing of Secondary Offering of 9,200,000 Shares of Common Stock

BANNOCKBURN, Ill., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 9,200,000 shares of the Company's common stock in an underwritten public offering. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 9,200,000 Shares of Common Stock

Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Can Option Care (OPCH) Run Higher on Rising Earnings Estimates?

The company, which specializes in home infusion therapy, has risen more than 66% this year.

Why Shares of Option Care Health Are Popping Today

Mimecast

Bio-Techne

NEW YORK, Aug. 24, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the opening of trading on Monday, August 30: S&P MidCap 400 constituent Bio-Techne Corp. (NASD:TECH) will replace Maxim Integrated Products Inc. (NASD:MXIM) in the S&P 500, S&P SmallCap 600 constituent Saia Inc. (NASD:SAIA) will replace Bio-Techne in the S&P MidCap 400, and BioLife Solutions Inc. (NASD:BLFS) will replace Saia in the S&P SmallCap 600. S&P 500 constituent Analog Devices Inc. (NASD:ADI) is acquiring Maxim Integrated Products in a deal pending final conditions.

Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600

BANNOCKBURN, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 18,000,000 shares of the Company's common stock at a price to the public of $20.25 per share in an underwritten public offering. The number of shares of common stock to be sold was increased to 18,000,000 shares from the previously announced 15,000,000 shares. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 2,700,000 additional shares of common stock. The offering is expected to close on August 5, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Upsizing and Pricing of Secondary Offering of 18,000,000 Shares of Common Stock

BANNOCKBURN, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 15,000,000 shares of the Company's common stock in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 2,250,000 additional shares of common stock. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 15,000,000 Shares of Common Stock

Option Care Health, Inc. (OPCH) CEO John Rademacher on Q2 2021 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 125.00% and 9.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates

Shares of Option Care Health (NASDAQ:OPCH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 550.00% year over year to $0.18, which beat the estimate of $0.09.

Recap: Option Care Health Q2 Earnings

BANNOCKBURN, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2021.

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2021

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”)(Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, superior clinical outcomes and a highly satisfying patient experience.

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Reports Next Week: Wall Street Expects Earnings Growth

MONTREAL and BANNOCKBURN, Ill., July 21, 2021 (GLOBE NEWSWIRE) -- AlayaCare, a global home and community care software company, and Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services in the United States, announced today that they have formally established a technology collaboration to develop innovative software for alternate site infusion therapy. This co-development effort builds upon the companies' existing relationship, under which Option Care Health utilizes AlayaCare's existing software to manage its clinical resources at the point of care.

AlayaCare and Option Care Health Announce Joint Technology Collaboration Agreement

BANNOCKBURN, Ill., July 13, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2021 on Tuesday, August 3, 2021 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Second Quarter 2021 Financial Results and Host Conference Call

Option Care Health: Reopening With Strong Growth In Home Health Care Services

BANNOCKBURN, Ill., June 08, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 15,000,000 shares of the Company's common stock at a price to the public of $20.00 per share in an underwritten public offering. The number of shares of common stock to be sold was increased to 15,000,000 shares from the previously announced 10,000,000 shares. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 2,250,000 additional shares of common stock. The offering is expected to close on June 10, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Upsizing and Pricing of Secondary Offering of 15,000,000 Shares of Common Stock

BANNOCKBURN, Ill., June 08, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 10,000,000 shares of the Company's common stock in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 1,500,000 additional shares of common stock. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 10,000,000 Shares of Common Stock

BANNOCKBURN, Ill., May 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that John C. Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, will participate in the following upcoming investor conferences:

Option Care Health to Participate in Upcoming Virtual Investor Conferences

Option Care Health (OPCH) CEO John Rademacher on Q1 2021 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of -200.00% and 0.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Reports Q1 Loss, Tops Revenue Estimates

BANNOCKBURN, Ill., May 06, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2021.

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2021

BANNOCKBURN, Ill., May 03, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will present at the Bank of America 2021 Health Care Conference on Tuesday, May 11, 2021. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at 8:45 a.m. EDT.

Option Care Health to Participate in Upcoming Virtual Investor Conference

BANNOCKBURN, Ill., April 15, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2021 on Thursday, May 6, 2021 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

News for Option Care Health Stock (OPCH)